Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: SWL001
MIFTS: 36

Swallowing Disorders

Categories: Gastrointestinal diseases, Neuronal diseases
Tissues Related diseases Publications Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Swallowing Disorders

About this section

MalaCards integrated aliases for Swallowing Disorders:

Name: Swallowing Disorders 55 44
Deglutition Disorders 74

Classifications:

MalaCards categories:
Anatomical: Gastrointestinal diseases Neuronal diseases
See all MalaCards categories (disease lists)


External Ids:

UMLS 74 C0011168
Sources

Summaries for Swallowing Disorders

About this section
NINDS : 55 Having trouble swallowing (dysphagia) is a symptom that accompanies a number of neurological disorders. The problem can occur at any stage of the normal swallowing process as food and liquid move from the mouth, down the back of the throat, through the esophagus and into the stomach. Difficulties can range from a total inability to swallow, to coughing or choking because the food or liquid is entering the windpipe, which is referred to as aspiration. When aspiration is frequent a person can be at risk of developing pneumonia. Food may get "stuck" in the throat or individuals may drool because they cannot swallow their saliva. Neurological conditions that can cause swallowing difficulties are: stroke (the most common cause of dysphagia); traumatic brain injury; cerebral palsy; Parkinson disease and other degenerative neurological disorders such as amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig's disease), multiple sclerosis, progressive supranuclear palsy, Huntington disease, and myasthenia gravis. Muscular dystrophy and myotonic dystrophy are accompanied by dysphagia, which is also the cardinal symptom of oculopharyngeal muscular dystrophy, a rare, progressive genetic disorder.

MalaCards based summary : Swallowing Disorders, also known as deglutition disorders, is related to dysphagia and brain injury, and has symptoms including seizures, nausea and vomiting and constipation. The drugs Methylene blue and Fluorouracil have been mentioned in the context of this disorder. Affiliated tissues include testes, tongue and brain.

MedlinePlus : 44 If you have a swallowing disorder, you may have difficulty or pain when swallowing. Some people cannot swallow at all. Others may have trouble swallowing liquids, foods, or saliva. This makes it hard to eat. Often, it can be difficult to take in enough calories and fluids to nourish your body. Anyone can have a swallowing disorder, but it is more likely in the elderly. It often happens because of other conditions, including Nervous system disorders, such as Parkinson's disease and cerebral palsy Problems with your esophagus, including GERD (gastroesophageal reflux disease) Stroke Head or spinal cord injury Cancer of the head, neck, or esophagus Medicines can help some people, while others may need surgery. Swallowing treatment with a speech-language pathologist can help. You may find it helpful to change your diet or hold your head or neck in a certain way when you eat. In very serious cases, people may need feeding tubes. NIH: National Institute on Deafness and Other Communication Disorders

Wikipedia : 77 Dysphagia is difficulty in swallowing. Although classified under "symptoms and signs" in ICD-10, in some... more...

Sources

Related Diseases for Swallowing Disorders

About this section

Diseases related to Swallowing Disorders via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 40)
# Related Disease Score Top Affiliating Genes
1 dysphagia 10.2
2 brain injury 10.0
3 parkinson disease, late-onset 9.9
4 tracheoesophageal fistula with or without esophageal atresia 9.9
5 traumatic brain injury 9.9
6 esophageal atresia 9.9
7 dementia 9.9
8 neuromuscular disease 9.9
9 pneumonia 9.9
10 oral cancer 9.9
11 rheumatoid arthritis 9.7
12 schizophrenia 9.7
13 down syndrome 9.7
14 lung cancer 9.7
15 pierre robin syndrome 9.7
16 sjogren syndrome 9.7
17 tardive dyskinesia 9.7
18 anxiety 9.7
19 arthritis 9.7
20 cerebral palsy 9.7
21 diabetic neuropathy 9.7
22 aspiration pneumonia 9.7
23 oromandibular dystonia 9.7
24 aphasia 9.7
25 muscular disease 9.7
26 mucositis 9.7
27 autosomal dominant cerebellar ataxia 9.7
28 hyperostosis 9.7
29 ischemia 9.7
30 biliary dyskinesia 9.7
31 myopathy 9.7
32 blepharospasm 9.7
33 dystonia 9.7
34 diffuse idiopathic skeletal hyperostosis 9.7
35 cerebrovascular disease 9.7
36 oropharynx cancer 9.7
37 neuropathy 9.7
38 depression 9.7
39 isolated pierre robin sequence 9.7
40 myotonia 9.7

Comorbidity relations with Swallowing Disorders via Phenotypic Disease Network (PDN): (show top 50) (show all 62)


Active Peptic Ulcer Disease Acute Cystitis
Acute Kidney Failure Alzheimer Disease
Bronchitis Bronchopneumonia
Cerebral Atherosclerosis Cerebral Degeneration
Cerebrovascular Disease Chronic Myocardial Ischemia
Conjunctivitis Decubitus Ulcer
Deficiency Anemia Dyskinesia of Esophagus
Encephalopathy Epilepsy, Focal, with Speech Disorder and with or Without Mental Retardation
Esophageal Cancer Esophageal Candidiasis
Esophageal Disease Esophagitis
Facial Paralysis Familial Atrial Fibrillation
Generalized Atherosclerosis Heart Disease
Hypertension, Essential Hypothyroidism
Intermittent Claudication Intracranial Embolism
Intracranial Thrombosis Iron Deficiency Anemia
Ischemic Heart Disease Kidney Disease
Kwashiorkor Larynx Cancer
Major Depressive Disorder Malignant Essential Hypertension
Marasmus Megaesophagus
Myasthenia Gravis Congenital Neurogenic Bladder
Neuromuscular Disease Nutritional Deficiency Disease
Obstructive Hydrocephalus Ocular Motor Apraxia
Oral Candidiasis Osteoporosis
Paralytic Ileus Parkinson Disease, Late-Onset
Peripheral Vascular Disease Pharyngitis

Graphical network of the top 20 diseases related to Swallowing Disorders:



Diseases related to Swallowing Disorders
Sources

Symptoms & Phenotypes for Swallowing Disorders

About this section

UMLS symptoms related to Swallowing Disorders:


seizures, nausea and vomiting, constipation, vomiting, abdominal pain, headache, diarrhea, nausea, pseudobulbar signs, icterus, signs and symptoms, digestive, dyspepsia, heartburn, gastrointestinal gas, digestive system symptom, flatulence, eructation, and gas pain, symptoms involving digestive system, other symptoms involving digestive system, odynophagia, pain in esophagus (finding), absent deglutition, swallowing problems, choking sensation, symptom as reason for upper g.i. examination, dysphagia, pharyngeal phase, dysphagia, pharyngoesophageal phase
Sources

Drugs & Therapeutics for Swallowing Disorders

About this section

Drugs for Swallowing Disorders (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 650)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Methylene blue Approved, Investigational Phase 4,Phase 1,Phase 2,Not Applicable 61-73-4
2
Fluorouracil Approved Phase 4,Phase 3,Phase 2,Not Applicable 51-21-8 3385
3
Cetuximab Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 205923-56-4 56842117 2333
4
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 73590-58-6 4594
5
Domperidone Approved, Investigational, Vet_approved Phase 4,Phase 3,Not Applicable 57808-66-9 3151
6
Dopamine Approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 62-31-7, 51-61-6 681
7
Trimebutine Approved Phase 4 39133-31-8
8
Rabeprazole Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 117976-89-3 5029
9
Dexlansoprazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 138530-94-6, 103577-45-3 9578005
10
Lansoprazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 103577-45-3 3883
11
Esomeprazole Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 161796-78-7, 161973-10-0, 119141-88-7 9568614 4594
12
Calcium polycarbophil Approved Phase 4 126040-58-2
13
mometasone furoate Approved, Investigational, Vet_approved Phase 4,Phase 2 83919-23-7
14
Acetylcholine Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 51-84-3 187
15
Acetaminophen Approved Phase 4,Phase 3,Not Applicable 103-90-2 1983
16
Fluticasone Approved, Experimental Phase 4,Phase 3,Phase 2,Not Applicable 90566-53-3 62924
17
Chlorhexidine Approved, Vet_approved Phase 4,Phase 3,Not Applicable 55-56-1 2713 9552079
18
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Phase 3,Not Applicable 437-38-7 3345
19
Racepinephrine Approved Phase 4,Not Applicable 329-65-7 838
20
Epinephrine Approved, Vet_approved Phase 4,Not Applicable 51-43-4 5816
21
Pantoprazole Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 102625-70-7 4679
22
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 50-02-2 5743
23
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 1177-87-3
24
Zinc Approved, Investigational Phase 4,Not Applicable 7440-66-6 32051
25
Prednisone Approved, Vet_approved Phase 4,Phase 1,Not Applicable 53-03-2 5865
26
Remifentanil Approved Phase 4,Not Applicable 132875-61-7 60815
27
Levobupivacaine Approved, Investigational Phase 4 27262-47-1 92253
28
Benzocaine Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 1994-09-7, 94-09-7 2337
29
Tyrothricin Approved Phase 4 1404-88-2
30
tannic acid Approved Phase 4,Phase 3,Phase 2,Not Applicable 1401-55-4
31
Budesonide Approved Phase 4,Phase 3,Phase 2,Not Applicable 51333-22-3 5281004 63006
32
Naloxone Approved, Vet_approved Phase 4 465-65-6 5284596
33
Metoclopramide Approved, Investigational Phase 4,Phase 3,Not Applicable 364-62-5 4168
34
Benzydamine Approved Phase 4,Phase 1 642-72-8, 100-46-9 7504
35
Morphine Approved, Investigational Phase 4,Not Applicable 57-27-2 5288826
36
Famotidine Approved Phase 4,Phase 3,Phase 2,Not Applicable 76824-35-6 3325
37
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 51-45-6 774
38
Clotrimazole Approved, Vet_approved Phase 4,Phase 3 23593-75-1 2812
39
Nystatin Approved, Vet_approved Phase 4 1400-61-9 11953884
40
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
41
Tacrolimus Approved, Investigational Phase 4 104987-11-3 6473866 445643 439492
42
Propofol Approved, Investigational, Vet_approved Phase 4,Phase 3,Not Applicable 2078-54-8 4943
43
Isoflurane Approved, Vet_approved Phase 4 26675-46-7 3763
44
Rocuronium Approved Phase 4,Not Applicable,Early Phase 1 119302-91-9, 143558-00-3 441290
45
Oxybutynin Approved, Investigational Phase 4,Phase 3 5633-20-5 4634
46
Propranolol Approved, Investigational Phase 4 525-66-6 4946
47
Meloxicam Approved, Vet_approved Phase 4 71125-38-7 54677470 5281106
48
Diclofenac Approved, Vet_approved Phase 4,Phase 2,Phase 3 15307-86-5 3033
49
Codeine Approved, Illicit Phase 4 76-57-3 5284371
50
Guaifenesin Approved, Investigational, Vet_approved Phase 4,Phase 1,Phase 2 93-14-1 3516

Interventional clinical trials:

(show top 50) (show all 1729)
# Name Status NCT ID Phase Drugs
1 Personalized Peroral Endoscopic Myotomy for Achalasia Unknown status NCT01570621 Phase 4
2 Cetuximab Compared to Mitomycin-C and 5-Fluorouracil for Locally Advanced Squamous Cell Carcinomas of the Head and Neck Unknown status NCT02015650 Phase 4 Cetuximab;Mitomycin-C/ 5-Fluorouracil
3 Research of Efficient Use of Omeprazole in Combination With Domperidone in Gastroesophageal Reflux Disease of Mild to Moderate Severity Unknown status NCT02140073 Phase 4 omeprazole+domperidone SR;omeprazole
4 Evaluation of Low-level Laser at Auriculotherapy Points to Reduce Postoperative Pain in Inferior Third Molar Surgery Unknown status NCT02657174 Phase 4
5 Trimebutine Maleate Combined With Rabeprazole in Patients With Grade A or B Reflux Esophagitis Whose Symptoms Refractory to Rabeprazole Unknown status NCT02986685 Phase 4 Trimebutine Maleate;rabeprazole
6 Effect of Magnesium Alginate on Gastroesophageal Reflux in Infants. Unknown status NCT02806453 Phase 4
7 Treatment Effect Between Dexlansoprazole and Double-dose Lansoprazole in Obesity Patients With Reflux Esophagitis Unknown status NCT02759393 Phase 4 Dexlansoprazole;Lansoprazole
8 Esomeprazole Plus Alginate vs. Esomeprazole Alone for Treatment of Nighttime Reflux Symptom and Sleep Disturbances Unknown status NCT02277886 Phase 4 sodium alginate;esomeprazole
9 Phase IV Study of the Impact of Dietary Fibers on Symptoms and Esophageal Motility in Patients With Non-erosive GERD Unknown status NCT01882088 Phase 4 Mucofalk
10 Randomized, Double Blind, Placebo Control Trial to Evaluate the Efficacy of Wu-Chu-Yu Tang on Gastroesophageal Reflux Disease (GERD) Unknown status NCT01822106 Phase 4
11 LGG for Prevention of Infectious Complications During PPI Treatment in Children Unknown status NCT01782118 Phase 4
12 Development of Applications of the Bravo® pH Monitoring System and Evaluation of Its Performance Unknown status NCT01503476 Phase 4
13 Dexlansoprazole to Treat Laryngopharyngeal Reflux and Lingual Tonsil Hypertrophy Unknown status NCT01328652 Phase 4 dexlansoprazole
14 The Relationship Between Gastroesophageal Reflux and Pediatric Rhinitis: Significance of Pale/Blue Colored Turbinate Unknown status NCT02278081 Phase 4 lansoprazole;placebo
15 A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy. Unknown status NCT00237068 Phase 4 Lansoprazole; Solutab
16 Opioid Induced Swallowing Difficulties and Risk for Pulmonary Aspiration Completed NCT01495377 Phase 4 Remifentanil;Placebo;Technetium
17 Pediatric Dysphagia Outcomes After Injection Laryngoplasty for Type I Laryngeal Cleft Completed NCT01507207 Phase 4
18 Evaluation of Two Different Thickening Products in Patients With Dysphagia Completed NCT01651975 Phase 4
19 Neuromuscular Electroestimulation and Respiratory Muscle Training in Subacute Stroke Completed NCT02473432 Phase 4
20 Repetitive Transcranial Stimulation (rTMS) in Post Stroke Dysphagia Completed NCT01081444 Phase 4
21 Effect of Laryngeal Mask Cuff Pressure in Geriatric Patients Completed NCT02189954 Phase 4
22 Peritonsillar Infiltration With Levobupivacaine for Posttonsillectomy Pain Completed NCT02322346 Phase 4 Group LL;Group HL
23 Comparison of Efficacy and Safety of Two Different Types of Botulinum Toxin Type A in Moderate to Severe Cervical Dystonia Completed NCT00528541 Phase 4
24 Safety and Efficacy of a Sore Throat Lozenge DORITHRICIN in Patients With Acute Pharyngitis Completed NCT03323528 Phase 4 Benzalkonium Chloride-Benzocaine Topical;Placebo Oral Tablet
25 Acetaminophen's Efficacy For Post-operative Pain Completed NCT01721486 Phase 4 IV acetaminophen;PO acetaminophen
26 Budesonide Versus Fluticasone for Treatment of Eosinophilic Esophagitis Completed NCT02019758 Phase 4 Oral Viscous Budesonide;Fluticasone MDI;Placebo slurry;Placebo inhaler
27 Opioid Effects on Swallowing and Esophageal Sphincter Pressure Completed NCT01191645 Phase 4 naloxone;remifentanil;Sodium Chloride;metoclopramide
28 To Evaluate the Effect of Chlorhexidine-benzidamine Administration Completed NCT03253497 Phase 4 Chlorobenzene Liquid
29 Opioid Effects on Swallowing Comparing Younger and Elderly Volunteers Completed NCT01924234 Phase 4 Morphine;Remifentanil
30 Ulcer Prevention Study in Post Gastric Bypass Patients Completed NCT00557349 Phase 4 Omeprazole;Famotidine
31 WallFlex Esophageal Fully Covered (FC) Benign Anastomotic Stricture Completed NCT01699542 Phase 4
32 Esophageal Fully Covered Metal Stents in Caustic Strictures Study Completed NCT01899300 Phase 4
33 Blind Intubation Through The Self-Pressurised Disposable Air-Q Laryngeal Intubation Mask: An International Multicentre Trial Completed NCT01906060 Phase 4
34 Pharmacokinetics of Sublingual Versus Oral Tacrolimus in Patients Awaiting Kidney Transplantation Completed NCT00629122 Phase 4 Tacrolimus (Arm B);Clotrimazole Troche;Tacrolimus (Arm A);Nystatin Suspension
35 Comparing Hemodynamic Changes for Intubation With Shikani Intubating Stylet and Macintosh Laryngoscope Completed NCT01271543 Phase 4
36 An Efficacy Study to Compare the Treatment Effects of Rabeprazole and Lansoprazole Depending on the Genotyping of CYP2C19 in Treating Reflux Esophagitis Completed NCT01008696 Phase 4 Rabeprazole;Lansoprazole
37 Nissen and Gastroplasty in Gastroesophageal Reflux Disease (GERD) Completed NCT00872755 Phase 4
38 Study to Compare the Safety and Efficacy of Solifenacin With Oxybutynin for the Treatment of Overactive Bladder (VECTOR) Completed NCT00431041 Phase 4 solifenacin;oxybutynin immediate release
39 Safety and Efficacy of Lansoprazole in Patients With Reflux Disease Completed NCT01135368 Phase 4 Lansoprazole
40 A Multicenter, Randomized, Double Blind, Double Dummy, Parallel-Group Efficacy Study Comparing 8 Weeks of Treatment With Esomeprazole Magnesium (40mg qd) to Lansoprazole (30mg qd) for the Healing of Erosive Esophagitis in Patients With Moderate or Severe Erosive Esophagitis Completed NCT00641602 Phase 4 Esomeprazole;Lansoprazole
41 PROPRANOLOL PLUS LIGATION REDUCES RECURRENCE OF ESOPHAGEAL VARICES? Completed NCT01893541 Phase 4 PROPRANOLOL
42 Safety Study of MK-3641 and MK-7243 Co-administered in Adult Participants With Ragweed and Grass Pollen Induced Allergic Rhinitis (P08607, MK-3641-006) Completed NCT02256553 Phase 4 Rescue Medication
43 Compliance With Antidepressant Medication in Treatment of Functional Dyspepsia Completed NCT01851863 Phase 4 Omeprazole;Flupentixol-Melitracen(psychological and GI) + Omeprazole;Flupentixol-Melitracen(psychological) + Omeprazole;Flupentixol-Melitracen(without explanation) + Omeprazole
44 Efficacy and Safety Study of Ingavirin® 90 mg Once Daily to Treat Influenza and Other Acute Viral Infections in Adults Completed NCT03154515 Phase 4 Ingavirin;Placebo
45 An Open-Label Study of Once-Daily Oral Administration of Esomeprazole 40 mg in Patients With Symptoms of Gastroesophageal Reflux Disease (GERD) Completed NCT00242736 Phase 4 Esomeprazole
46 Efficacy and Safety of Meloxicam Suspension Versus Diclofenac Suspension or Nimesulide Suspension in Patients With a Diagnosis of Acute, Non-bacterial Pharyngitis, Pharyngotonsillitis or Laryngitis Completed NCT02229747 Phase 4 Meloxicam;Diclofenac;Nimesulide
47 Codeine on Pharyngeal and Esophageal Motility Completed NCT03784105 Phase 4 Codeine Phosphate;Siripus simplex
48 The Effect of Corticotrophin-releasing Hormone (CRH) on Esophageal Motility in Healthy Volunteers Completed NCT02736734 Phase 4 CRH
49 Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease Completed NCT02351960 Phase 4 Dexlansoprazole
50 A New Oral salIvary equivAlent Compared to Two moisturizinG Mouth sprAys in Patients With xeRostomiA: NIAGARA Study Completed NCT02049112 Phase 4

Search NIH Clinical Center for Swallowing Disorders

Sources

Genetic Tests for Swallowing Disorders

About this section
Sources

Anatomical Context for Swallowing Disorders

About this section

MalaCards organs/tissues related to Swallowing Disorders:

42
Testes, Tongue, Brain, Thyroid, Lung, Bone, Spinal Cord
Sources

Publications for Swallowing Disorders

About this section

Articles related to Swallowing Disorders:

(show top 50) (show all 203)
# Title Authors Year
1
Technology-enabled management of communication and swallowing disorders in Parkinson's disease: a systematic scoping review. ( 29923267 )
2019
2
Sarcopenia and swallowing disorders in older people. ( 30671866 )
2019
3
Effects of electromyographic biofeedback as an adjunctive therapy in the treatment of swallowing disorders: a systematic review of the literature. ( 30771061 )
2019
4
Usefulness of a modified questionnaire as a screening tool for swallowing disorders in Parkinson disease: A pilot study. ( 30860108 )
2019
5
Clinical identification of feeding and swallowing disorders in 0-6 month old infants with Down syndrome. ( 30588741 )
2018
6
Predictors of chewing and swallowing disorders after surgery for locally advanced oral cancer with free flap reconstruction: A prospective, observational study. ( 30217307 )
2018
7
Epidemiology of Swallowing Disorders in Rheumatoid Arthritis: Prevalence, Risk Factors, and Quality of Life Burden. ( 29911396 )
2018
8
Plugging the patient evidence gap: what patients with swallowing disorders post-stroke say about thickened liquids. ( 28621030 )
2018
9
Identification of swallowing disorders in early and mid-stage Parkinson's disease using pattern recognition of pharyngeal high-resolution manometry data. ( 29143418 )
2018
10
Evidence- and Consensus-Based Guidelines for the Management of Communication and Swallowing Disorders Following Pediatric Traumatic Brain Injury. ( 29385009 )
2018
11
In reference to Is multidisciplinary team care for head and neck cancer worth it? and Does a multidisciplinary approach to voice and swallowing disorders improve therapy adherence and outcome? ( 29537079 )
2018
12
Identification of swallowing disorders: the perception of patients with neurodegenerative diseases. ( 30517269 )
2018
13
Swallowing disorders among patients with diffuse idiopathic skeletal hyperostosis. ( 28084872 )
2017
14
European Society for Swallowing Disorders FEES Accreditation Program for Neurogenic and Geriatric Oropharyngeal Dysphagia. ( 28779300 )
2017
15
Oropharyngeal dysphagia: when swallowing disorders meet respiratory diseases. ( 28404653 )
2017
16
Swallowing disorders in Parkinson's disease. ( 27269197 )
2017
17
Taking the history in patients with swallowing disorders: an international multidisciplinary survey. ( 27730327 )
2017
18
History of the Use and Impact of Compensatory Strategies in Management of Swallowing Disorders. ( 28130600 )
2017
19
Diagnosis of Swallowing Disorders: How We Interpret Pharyngeal Manometry. ( 28289859 )
2017
20
Evaluating the quality and readability of Internet information sources regarding the treatment of swallowing disorders. ( 28346643 )
2017
21
Swallowing Disorders in Schizophrenia. ( 28447217 )
2017
22
Prevalence of Auditory Problems in Children With Feeding and Swallowing Disorders. ( 28492927 )
2017
23
Swallowing Disorders after Oral Cavity and Pharyngolaryngeal Surgery and Role of Imaging. ( 28496456 )
2017
24
Swallowing disorders after thyroidectomy: What we know and where we are. A systematic review. ( 28506421 )
2017
25
Does a multidisciplinary approach to voice and swallowing disorders improve therapy adherence and outcomes? ( 28699270 )
2017
26
Water-filtered infrared-A (wIRA) overcomes swallowing disorders and hypersalivation - a case report. ( 28794695 )
2017
27
Swallowing disorders and 1-year functional decline in community-dwelling older adults receiving home care. ( 28965365 )
2017
28
Presentation of a Clinical Practice Protocol for Patients with Swallowing Disorders. ( 29091113 )
2017
29
European Society for Swallowing Disorders - European Union Geriatric Medicine Society white paper: oropharyngeal dysphagia as a geriatric syndrome. ( 27785002 )
2016
30
Erratum to: Effect of Bolus Viscosity on the Safety and Efficacy of Swallowing and the Kinematics of the Swallow Response in Patients with Oropharyngeal Dysphagia: White Paper by the European Society for Swallowing Disorders (ESSD). ( 27444733 )
2016
31
Effect of Bolus Viscosity on the Safety and Efficacy of Swallowing and the Kinematics of the Swallow Response in Patients with Oropharyngeal Dysphagia: White Paper by the European Society for Swallowing Disorders (ESSD). ( 27016216 )
2016
32
Clinical Characteristics of Voice, Speech, and Swallowing Disorders in Oromandibular Dystonia. ( 27617622 )
2016
33
The effects of swallowing disorders, dysgeusia, oral mucositis and xerostomia on nutritional status, oral intake and weight loss in head and neck cancer patients: A systematic review. ( 27010487 )
2016
34
Evaluation of swallowing disorders by use of transnasal esophagoscopy in patients treated for head and neck cancer. ( 26331801 )
2016
35
Swallowing Disorders in Sjögren's Syndrome: Prevalence, Risk Factors, and Effects on Quality of Life. ( 26482060 )
2016
36
5th ESSD Congress, Swallowing Disorders: From Compensation to Recovery, Barcelona October 1-3, 2015. ( 27012276 )
2016
37
Swallowing Disorders in Severe Brain Injury in the Arousal Phase. ( 27090424 )
2016
38
Oropharyngeal and laryngeal sensory innervation in the pathophysiology of swallowing disorders and sensory stimulation treatments. ( 27442852 )
2016
39
Autoimmune swallowing disorders. ( 27585081 )
2016
40
Knowledge and practice concerning swallowing disorders in hemiplegic patients among nurses of Bobo-Dioulasso urban primary health care centers in Burkina Faso. ( 29430536 )
2016
41
Feeding and Swallowing Disorders in Esophageal Atresia Patients: A Review of a Critical Issue. ( 26309244 )
2015
42
Tracheostomy, swallowing disorders and rehabilitation: it is never too late. ( 25300628 )
2015
43
Swallowing disorders in Parkinson's disease: impact of lingual pumping. ( 25652413 )
2015
44
A videofluoroscopic study comparing severe swallowing disorders in patients treated surgically or with radiation for oropharyngeal cancer. ( 25697064 )
2015
45
Contemporary management of voice and swallowing disorders in patients with advanced lung cancer. ( 25887976 )
2015
46
Eagle's syndrome revealed by swallowing disorders: A case report. ( 25955380 )
2015
47
Quality of life in swallowing disorders after nonsurgical treatment for head and neck cancer. ( 25992151 )
2015
48
Position paper of the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery and the German Society of Phoniatrics and Pediatric Audiology - Current state of clinical and endoscopic diagnostics, evaluation, and therapy of swallowing disorders in children. ( 26770277 )
2015
49
Feeding and Swallowing Disorders in Pediatric Neuromuscular Diseases: An Overview. ( 27858755 )
2015
50
Effects of Repetitive Transcranial Magnetic Stimulation in the Rehabilitation of Communication and Deglutition Disorders: Systematic Review of Randomized Controlled Trials. ( 26580744 )
2015
Sources

Variations for Swallowing Disorders

About this section
Sources

Expression for Swallowing Disorders

About this section
Search GEO for disease gene expression data for Swallowing Disorders.
Sources

Pathways for Swallowing Disorders

About this section
Sources

GO Terms for Swallowing Disorders

About this section
Sources

Sources for Swallowing Disorders

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....